Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
Dewald, F.; Prikl, M.; Ahmadov, E.; Paluschinski, M.; Kuehn, J.; Elsner, C.; Schulte, B.; Schlotz, M.; Oral, G.; Knuefer, J.; Bernhard, M.; Michael, M.; Luxenburger, M.; Andree, M.; Hennies, M. T.; Hafezi, W.; Mueller, M. M.; Kuempers, P.; Risse, J.; Kill, C.; Manegold, R. K.; von Frantzki, U.; Schulte, B.; Richter, E.; Monzon Posadas, W.; Graeff, I.; Kogej, M.; Buening, A.; Baum, M.; Teipel, F.; Mochtarzadeh, B.; Wolff, M.; Gruell, H.; Di Cristanziano, V.; Burst, V.; Streeck, H.; Dittmer, U.; Ludwig, S.; Timm, J.; Klein, F.
Show abstract
Determining SARS-CoV-2 immunity is critical to assess COVID-19 risk and the need for prevention and mitigation strategies. We measured SARS-CoV-2 Spike/Nucleocapsid seroprevalence and serum neutralizing activity against Wu01, BA.4/5 and BQ.1.1 in 1,411 individuals who received medical treatment in five emergency departments in North Rhine-Westphalia, Germany. We detected Spike-IgG in 95.6%, Nucleocapsid-IgG in 24.0% and neutralization against Wu01, BA.4/5 and BQ.1.1 in 94.4%, 85.0%, and 73.8% of participants, respectively. Neutralization against BA.4/5 and BQ.1.1 was reduced 5.6- and 23.4-fold compared to Wu01. Accuracy of S-IgG detection for determination of neutralizing activity against BQ.1.1 was reduced substantially. Furthermore, we explored previous vaccinations and infections as most important correlates of improved BQ.1.1 neutralization using multivariable and Bayesian network analyses. Given an adherence to COVID-19 vaccination recommendations of only 67.7% of all participants, we highlight the need for improvement of vaccine-uptake to reduce the COVID-19 risk in upcoming infection-waves with immune evasive variants.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19 97%
- Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2 97%
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 96%
Similar papers in this journal
- Follow-up study in the ski-resort Ischgl: Antibody and T cell responses to SARS-CoV-2 persisted for up to 8 months after infection and transmission of virus was low even during the second infection wave in Austria 97%
- Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines 96%
- Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 96%
Similar papers in this journal
- Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infection 97%
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 96%
- Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies 95%
Similar papers in this journal
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant 96%
- Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens 94%
- Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies 94%
Similar papers in this journal
- Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region 96%
- Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques 96%
- Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.